Detection of Ustekinumab in Breast Milk of Nursing Mothers With Crohn Disease

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

(2019) Bruce E. Sands et al.   NEW ENGLAND JOURNAL OF MEDICINE

Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development

(2018) Rebecca Matro et al.   GASTROENTEROLOGY

Drug Levels in the Maternal Serum, Cord Blood and Breast Milk of a Ustekinumab-Treated Patient with Crohn’s Disease

(2018) Entcho Klenske et al.   Journal of Crohns & Colitis

Vedolizumab Levels in Breast Milk of Nursing Mothers With Inflammatory Bowel Disease

(2017) Adi Lahat et al.   Journal of Crohns & Colitis

Ustekinumab therapy for Crohn's disease during pregnancy: a case report and review of the literature

(2016) X. Cortes et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease

(2011) Shomron Ben-Horin et al.   Journal of Crohns & Colitis

The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful

(2010) S. Ben-Horin et al.   GUT

Transfer of antibodies across the placenta and in breast milk from mothers on intravenous immunoglobulin

(2009) Patricia Palmeira et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY